Rapid Dose Therapeutics Announces Appointment of Dr. Gabriela Radulescu as Medical Director
Burlington, Ontario--(Newsfile Corp. - January 23, 2019) - Rapid Dose Therapeutics (CSE: DOSE) ("RDT") is pleased to announce the appointment of Dr. Gabriela Radulescu as Medical Director for RDT. Dr. Radulescu is a physician with 20 years of experience in the pharmaceutical industry. She brings to the RDT team strong strategic and operational medical leadership that will enhance the dialogue with pharmaceutical companies wanting to offer QuickStrip™ technology to their patient base. Dr....
2019-01-23 7:00 AM EST
Rapid Dose Therapeutics Announces Launch of Its Innovative QuickStrip(TM) Product to the Nevada Cannabis Market Through Brand Partnership with Flower One
Burlington, Ontario--(Newsfile Corp. - January 15, 2019) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT") is pleased to announce its entered into a definitive agreement (the "Agreement") on January 10, 2019, with Flower One Holdings Inc. (CSE: FONE) (OTCQB: FLOOF)("Flower One") pursuant to which Flower One has been granted license to manufacture, distribute and sell RDT's QuickStrip™, an innovative, proprietary delivery technology for the cannabis market in Nevada. Flower One expects to...
2019-01-15 12:56 PM EST
Rapid Dose Therapeutics and Aphria to Deliver Innovative QuickStrip(TM) Technology to the German Cannabis Market
Ontario and Leamington, Ontario--(Newsfile Corp. - December 18, 2018) - Rapid Dose Therapeutics Inc. (CSE: DOSE) ("RDT" or the "Company") and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) announced today that they have expanded the scope of their previously announced agreement (the "Agreement"), executed on November 1, 2018 (see the Company's press release dated November 5, 2018), expanding the territory where Aphria has been granted exclusive preferred rights to license, manufacture,...
2018-12-18 7:44 AM EST
Rapid Dose Therapeutics Begins Trading on the CSE Under the Ticker "DOSE"
Burlington, Ontario--(Newsfile Corp. - December 17, 2018) - Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) (CSE: DOSE) ("RDT" or the "Corporation") is pleased to announce that, following completion of the business combination with Rapid Dose Therapeutics Inc., the Corporation's Common Shares will commence trading on the Canadian Securities Exchange (the "CSE") under the four-letter ticker symbol "DOSE" effective as of the opening of the market today. RDT's CEO, Mark Upsdell,...
2018-12-17 8:15 AM EST
ACME Resources Announces Change of Name to Rapid Dose Therapeutics Corp. and Changes of Directors and Officers
Toronto, Ontario--(Newsfile Corp. - December 10, 2018) - Further to its press release of December 7, 2018, Rapid Dose Therapeutics Corp. (formerly ACME Resources Corp.) ("ACME" or the "Corporation"), is pleased to announce the change of its name from ACME Resources Corp. to Rapid Dose Therapeutics Corp. in connection with the completion of its business combination with Rapid Dose Therapeutics Inc. ("RDT"). In addition, the Corporation welcomes its new board members, Messrs. Mark Upsdell,...
2018-12-10 4:52 PM EST
ACME Resources and Rapid Dose Therapeutics Announce Completion of Amalgamation
Toronto and Burlington, Ontario--(Newsfile Corp. - December 7, 2018) - ACME Resources Corp. ("ACME" or the "Corporation") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to jointly announce the completion of the three-cornered amalgamation pursuant to an Amended and Restated Amalgamation Agreement (the "Amalgamation Agreement") as of July 11, 2018 as further amended (the "Transaction"). As announced in the Corporation's press release of July 12, 2018, ACME entered into the Amalgamation...
2018-12-07 6:22 PM EST
ACME Resources Announces Filing of Final Non-Offering Prospectus
Toronto, Ontario--(Newsfile Corp. - December 6, 2018) - ACME Resources Corp. ("ACME" or the "Corporation") is pleased to announce that it has received a receipt from the Ontario Securities Commission for the filing of its final non-offering long form prospectus. A copy of the prospectus is available under the Corporation's profile on SEDAR (www.sedar.com). The Corporation is also pleased to announce that the Canadian Securities Exchange (the "CSE") has conditionally approved the listing of...
2018-12-06 7:46 PM EST
Rapid Dose Therapeutics Announces Agreement with Chemesis International to License QuickStrip(TM) Technology in Puerto Rico
Toronto and Burlington, Ontario--(Newsfile Corp. - November 7, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT's United States subsidiary, RDT Therapeutics Inc. ("RDT-US"), has signed an additional definitive five-year, renewable Managed Strip Services (MSS) Agreement with Chemesis International Inc. (CSE: CSI) ("Chemesis") for the territory of Puerto Rico. Under the Managed Strip Services Agreement, Chemesis has...
2018-11-07 3:17 PM EST
Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria
Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a...
2018-11-05 9:31 AM EST
ACME Resources Announces Rapid Dose Therapeutics Wins Top Ten in Grocery Award at Grocery Innovations Canada
Ontario and Burlington, Ontario--(Newsfile Corp. - October 30, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT"), a Canadian bio-technology company focused on providing disruptive proprietary drug delivery technologies for the nutraceutical, therapeutic and pharamecutical market, are pleased to announce that RDT's "QuickStrip™" product won the highly respected "Top Ten in Grocery" award for non-food category at the Grocery Innovations Canada...
2018-10-30 9:20 AM EDT
ACME Resources Announces Rapid Dose Therapeutics Signs a Definitive Agreement with Chemesis International
Toronto and Burlington, Ontario--(Newsfile Corp. - October 12, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT"), a bio-technology company focused on innovative drug delivery solutions designed to improve patient outcomes, announced today, that RDT's United States subsidiary, RDT Therapeutics Inc. ("RDT-US"), has signed a five-year, renewable Managed Strip Services (MSS) Agreement with Chemesis International Inc. (CSE: CSI) ("Chemesis"). Under the...
2018-10-12 1:04 PM EDT
ACME Resources and Rapid Dose Therapeutics Announce Filing of Defence in Court Proceeding Commenced Against Rapid Dose Therapeutics
Toronto and Burlington, Ontario--(Newsfile Corp. - October 10, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT") announce that RDT has filed its Statement of Defence in response to legal proceedings commenced against RDT in the Ontario Superior Court of Justice by CTT Pharmaceutical Holdings Inc. ("CTT"). See News Release dated September 28, 2018 (available on ACME's profile on SEDAR at www.sedar.com). In its Statement of Defence, RDT denies the...
2018-10-10 7:27 PM EDT
ACME Resources and Rapid Dose Therapeutics Announce Court Proceeding Commenced Against Rapid Dose Therapeutics
Toronto and Burlington, Ontario--(Newsfile Corp. - September 28, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") announce that RDT was served yesterday afternoon with a Statement of Claim issued in the Ontario Superior Court of Justice by CTT Pharmaceutical Holdings Inc. ("CTT") claiming that RDT used confidential information provided by CTT relating to oral thin film technology, breached obligations of confidence and interfered with CTT's economic interests....
2018-09-28 9:36 AM EDT
ACME Resources Announces Results of Shareholder Meetings and RDT Financing
Toronto, Ontario--(Newsfile Corp. - September 5, 2018) - ACME Resources Corp. ("ACME" or the "Company") is pleased to announce the results of the ACME annual and special meeting of shareholders (the "ACME Meeting") and the results of the Rapid Dose Therapeutics Inc. ("RDT") special meeting of shareholders (the "RDT Meeting"), which were held on August 30 and 27, 2018, respectively. Voting Results At the ACME Meeting, shareholders holding approximately 52% of the outstanding shares were...
2018-09-05 8:23 AM EDT
ACME Resources and Rapid Dose Therapeutics Proceed to Shareholder Meetings to Approve their Proposed Merger and Provide Update on Scientific Research
Ontario and Burlington, Ontario--(Newsfile Corp. - August 13, 2018) - ACME Resources Corp. ("ACME" or the "Company") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that ACME has mailed the Notice and Management Information Circular for its shareholders meeting scheduled for August 30, 2018 and RDT will be sending its shareholder meeting materials to its shareholders this week. Among other things, their shareholders will be asked to approve their proposed reverse take-over...
2018-08-13 1:53 PM EDT
ACME Resources Corp. Announces Filing of Non-Offering Preliminary Prospectus
Toronto, Ontario--(Newsfile Corp. - July 16, 2018) - ACME Resources Corp. ("ACME" or the "Company") is pleased to announce that it has filed a non-offering preliminary prospectus with the Ontario Securities Commission. The non-offering preliminary prospectus was filed for the purpose of allowing the Company to comply with Policy 2 — Qualifications for Listing of the Canadian Securities Exchange ("CSE") in order for the Company to meet one of the eligibility requirements for the listing of...
2018-07-16 12:12 PM EDT
ACME Resources Corp. Announces Amended and Restated Amalgamation Agreement to Acquire Rapid Dose Therapeutics
Toronto, Ontario--(Newsfile Corp. - July 12, 2018) - ACME Resources Corp. ("ACME" or the "Company") is pleased to announce it has entered into an Amended and Restated Amalgamation Agreement (the "Amalgamation Agreement") as of July 11, 2018 to acquire 100% of the issued share capital of Rapid Dose Therapeutics Inc. ("RDT") in a Reverse Take-Over transaction (the "Transaction") payable by the issuance of approximately 57,641,200 common shares of ACME (each a "Common Share"). This agreement...
2018-07-12 12:21 PM EDT
Acme Resources Corp. Announces Changes to Its Board of Directors and Management
Toronto, Ontario--(Newsfile Corp. - June 6, 2018) - ACME Resources Corp. (the "Company") announces that Messrs. Paul R. Ankcorn, Brian M. Cloney, C.A. and Harry Burgess, P.Eng. have resigned as Directors of the Company, effective immediately. Mr. Ankcorn also steps down as C.E.O., and Mr. Cloney steps down as C.F.O. and Corporate Secretary. The Company would like to thank Messrs. Ankcorn, Cloney and Burgess for their collective many years of service to the Company. The Board of Directors of...
2018-06-06 4:15 PM EDT
ACME Resources Corp. Signs Definitive Agreement to Acquire Rapid Dose Therapeutics
Toronto, Ontario--(Newsfile Corp. - April 9, 2018) - ACME Resources Corp. ("ACME" or the "Company") is pleased to announce it has entered into a definitive agreement to acquire 100% of the issued share capital of Rapid Dose Therapeutics Inc. ("RDT") in a Reverse Take-Over transaction (the "Transaction") payable by the issuance of up to 57,130,000 common shares of ACME, which shares will include a private placement by RDT, prior to closing, for gross proceeds of up to $2,000,000. The Company...
2018-04-09 4:21 PM EDT
ACME Resources Corp. Closes Financing
Toronto, Ontario--(Newsfile Corp. - March 29, 2018) - ACME Resources Corp. (the "Company") announces that it has closed a non-brokered private-placement offering of 2,006,000 common shares issued at a price of $CDN 0.25 per share (the "Offering") for gross proceeds of $CDN 501,500.00. All securities issued in connection with the Offering are subject to a statutory four month plus one day hold period. The proceeds received from the Offering will be used for general working capital purposes...
2018-03-29 7:01 PM EDT